Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Percutaneous Delivery of Oncogel for Targeted Liver Tumor Ablation and Controlled Release of Therapeutics

Advanced Materials(2024)10.1002/adma.202406080Source: DataRank Database

Percutaneous Delivery of Oncogel for Targeted Liver Tumor Ablation and Controlled Release of Therapeutics is a research paper published in Advanced Materials (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.51)OA: hybridTopics (50)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Zefu Zhang ORCID,Hyeongseop Keum ORCID,Enes Çevik ORCID,Bolni Marius Nagalo ORCID,Şeyda Gündüz ORCID

Live enrichment

PubMed:39148179 PMC:PMC11543513 OpenAlex:https://openalex.org/W4401653171

National Institutes of Health

Grant: R01CA257558

National Institutes of Health

Grant: R01HL140951

National Institutes of Health

Grant: R01DK130566

National Institutes of Health

Grant: R01HL165176

National Institutes of Health

Grant: R01HL137193

NCI NIH HHS

Grant: P30 CA015083

Mayo Clinic: Christian Haub Family Career Development Award and the Mayo Clinic Clinician Investigator Award

FWCI

0.51

Citation Percentile

0.6%

Citation Trend

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/adma.202406080

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/adma.202406080

publisherhttps://advanced.onlinelibrary.wiley.com/doi/pdf/10.1002/adma.202406080

publisherhttps://advanced.onlinelibrary.wiley.com/doi/full-xml/10.1002/adma.202406080

journalhttps://doi.org/10.1002/adma.202406080

Fields of Study

Nanoplatforms for cancer theranosticsImmune cells in cancerNanoparticle-Based Drug DeliveryAnimalsDoxorubicinMiceLiver NeoplasmsHumansRabbitsRatsHydrogelsCell Line, TumorDelayed-Action PreparationsAntineoplastic AgentsDrug LiberationIonic LiquidsAblation Techniques

MeSH Terms

AnimalsAntineoplastic AgentsDelayed-Action PreparationsDoxorubicinHumansLiver NeoplasmsRabbitsHydrogelsCell Line, TumorMiceRatsIonic LiquidsAblation TechniquesDrug Liberation

Keywords

DoxorubicinImmunotherapyIn vivoDrug deliveryMedicineEx vivoCancer researchCancerLiver cancerPharmacologyAblationNivolumabChemotherapyMaterials scienceInternal medicineBiologyNanotechnologyBiomaterialIntratumoral

Sustainable Development Goals

SDG 0: Good health and well-being

Percutaneous Delivery of Oncogel for Targeted Liver Tumor Ablation and Controlled Release of Therapeutics

FAIR Checklist

Authors (8)

Funding (8 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)